Its announcement comes over the heels of the same licensing arrangement provided in February to Adastra Labs, which had till now centered on crafting cannabis extracts. The licensing deal arrives after a radical coverage shift to deal with an opioid overdose disaster which includes killed hundreds, by decriminalizing tiny quantities of copyrigh